Eisai Pharmaceuticals India
Hemant Nikam, Ph.D. has a diverse and extensive work experience in the field of human resources. Starting in 1995, they worked at Kopran Ltd. as an Executive Personnel and Admin, where they successfully established the entire site HR function and handled critical situations with Union, local agencies, and government authorities. HEMANT then worked at Indofil Chemical Company as a Sr. Executive Personnel, where they played a role in launching and executing an employee separation scheme. In 2002, they joined Schrader Duncan Ltd. as Head of Human Resources and Admin, where they played a leadership role and successfully handled HR responsibilities for four sites. HEMANT later worked at Unimark Remedies Ltd. as Deputy General Manager - Human Resources, where they established the corporate HR function and implemented centralized hiring and performance management systems. In 2007, they joined Hindustan Construction Company as Sr. Manager - Human Resources, overseeing HR operations for a large infrastructure development company. In 2008, they moved to CMI FPE LTD as Head of Human Resources, where they managed HR for a multinational engineering company. From 2010 to 2018, they worked at Perrigo API Pvt. Ltd. as Director Human Resources, responsible for the entire HR of all Indian operations and heading API India Operations. Most recently, since 2018, they have been serving as Vice President Human Resources at GHFL, handling HR responsibilities on a global scale. In 2022, they joined Eisai Pharmaceuticals India as Sr. Director and Head of Human Resources.
Hemant Nikam obtained their Bachelor's degree in Commerce and Master's degree in Labour Study (Human Resources) from the University of Mumbai between 1989 and 1995. Currently, they are pursuing a Doctor of Philosophy (Ph.D.) in Human Resources Management/Personnel Administration, General at Amity University Mumbai, a program they will complete in 2023.
This person is not in any offices
Eisai Pharmaceuticals India
2 followers
Welcome to Eisai India. Eisai (pronounced 'ā-zī’) is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Eisai is one of the world's leading research-based pharmaceutical companies. With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide. Eisai Pharmaceuticals India Pvt. Ltd. (Eisai India) was incorporated in October 2004, with registered office at Mumbai. Eisai Co.,Ltd was the first Japanese company to have a 100% subsidiary in Indian pharmaceutical market. Eisai India product portfolio includes prescription medicines in several therapeutic areas such as central nervous system disorders, metastatic breast cancer, benign prostrate hyperplasia , muscle spasm, vertigo, gastrointestinal disorders, diabetes and peripheral neuropathy. Eisai India has a dedicated team of well-trained 200 field force across the country under various specialties and more than 250 employees across Research and Manufacturing. We continuously work with Medical Doctors and the Healthcare professionals in India to ensure that they have updated information on our products so that they can prescribe the best products for the health care needs of their patients. Eisai India’s integrated Manufacturing and Research facility at Visakhapatnam (Vizag), Andhra Pradesh stimulates knowledge creation between teams – from those who create products through research, to those who produce - by bringing them together on one site and is supplemented by the necessary support functions. Eisai India’s Vizag facility manufactures Drug Substances (Active Pharmaceutical Ingredients-APIs), Drug Products (Oral solid dosage forms-Tablets) and carries out Developmental Research of Active Pharmaceutical Ingredients (APIs).This facility is registered as a pharmaceutical manufacturer at regulatory agencies viz USFDA, PMDA, MHRA and WHO. Research labs at Vizag facility are recognized by the Department of scientific and industrial research (DSIR). Facility also received the Certification of ISO 14001:2004 for Environment management system (EMS), OHSAS 18001 for Occupational Health and Safety Series and ISO 27001 for Information security management system from TUV SUD.